MX9307851A - Las espiropiperidinas y homologos promueven la liberacion de la hormona del crecimiento. - Google Patents
Las espiropiperidinas y homologos promueven la liberacion de la hormona del crecimiento.Info
- Publication number
- MX9307851A MX9307851A MX9307851A MX9307851A MX9307851A MX 9307851 A MX9307851 A MX 9307851A MX 9307851 A MX9307851 A MX 9307851A MX 9307851 A MX9307851 A MX 9307851A MX 9307851 A MX9307851 A MX 9307851A
- Authority
- MX
- Mexico
- Prior art keywords
- growth hormone
- promote
- release
- homologos
- spiropiperidines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06147—Dipeptides with the first amino acid being heterocyclic and His-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Se describen ciertos compuestos nuevos que se identifican como espiropiperidinas y homólogos que promueven la liberación de la hormona del crecimiento en humanos y animales. Esta propiedad se puede utilizar para promover el crecimiento de animales de comida para rendir la producción más eficiente de productos de carne comestible, y en humanos, para tratar condiciones fisiológicas ó médicas caracterizadas por una deficiencia en la secreción de la hormona del crecimiento, tales como corta estatura en niños deficientes de hormona del crecimiento, y para tratar condiciones médicas que se mejoran mediante los efectos anabólicos de la hormona del crecimiento. También se describen las composiciones de liberación de la hormona del crecimiento que contienen estos compuestos espiro como el ingrediente activo en los mismos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98932292A | 1992-12-11 | 1992-12-11 | |
US08/146,848 US5578593A (en) | 1992-12-11 | 1993-11-03 | Spiro piperidines and homologs promote release of growth hormone |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9307851A true MX9307851A (es) | 1994-06-30 |
Family
ID=26844355
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9307851A MX9307851A (es) | 1992-12-11 | 1993-12-10 | Las espiropiperidinas y homologos promueven la liberacion de la hormona del crecimiento. |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0662481B1 (es) |
JP (1) | JP2509147B2 (es) |
CN (1) | CN1040432C (es) |
AT (1) | ATE178070T1 (es) |
AU (1) | AU673017B2 (es) |
CA (1) | CA2110672A1 (es) |
DE (1) | DE69324148T2 (es) |
DZ (1) | DZ1735A1 (es) |
ES (1) | ES2129072T3 (es) |
HR (1) | HRP931484A2 (es) |
IL (1) | IL107836A (es) |
MX (1) | MX9307851A (es) |
PH (1) | PH31168A (es) |
SI (1) | SI9300647A (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
EP0900086A4 (en) * | 1996-05-07 | 2000-01-12 | Merck & Co Inc | IMPROVING THE SLEEP BY MEANS OF A SUBSTANCE PROMOTING THE SECRETION OF GROWTH HORMONES |
WO1998016527A1 (en) * | 1996-10-15 | 1998-04-23 | Fujisawa Pharmaceutical Co., Ltd. | Benzoxepine derivatives which promote release of growth hormone |
US6639076B1 (en) | 1998-08-18 | 2003-10-28 | Eli Lilly And Company | Growth hormone secretagogues |
CO5160260A1 (es) * | 1999-02-19 | 2002-05-30 | Lilly Co Eli | Secretagogos de la hormona del crecimiento derivados de imi- dazol 1,4- substituido |
US6828331B1 (en) | 1999-02-19 | 2004-12-07 | Eli Lilly And Company | Growth hormone secretagogues |
US7125840B2 (en) | 2001-10-09 | 2006-10-24 | Eli Lilly And Company | Substituted dipeptides as growth hormone secretagogues |
ES2271557T3 (es) | 2002-04-09 | 2007-04-16 | Eli Lilly And Company | Secretagogos dipeptidicos de la hormona del crecimiento. |
DE10317878A1 (de) * | 2003-04-17 | 2004-11-11 | Consortium für elektrochemische Industrie GmbH | Verfahren zur Herstellung von alpha-methylierten Cystein und Serin-Derivaten |
KR101285483B1 (ko) * | 2004-10-28 | 2013-07-12 | 상꾜 가부시키가이샤 | 광학 활성 4,4-2치환 옥사졸리딘 유도체와 그 제조 방법 |
CN101081835B (zh) * | 2006-05-30 | 2011-09-21 | 上海药明康德新药开发有限公司 | 一种螺[苯并环-3-酮-1-(4′-哌啶)]模板化合物的合成方法 |
JP5271917B2 (ja) * | 2007-01-12 | 2013-08-21 | メルク・シャープ・アンド・ドーム・コーポレーション | スピロクロマノン誘導体 |
JP5585822B2 (ja) * | 2010-05-11 | 2014-09-10 | 東レ・ファインケミカル株式会社 | 光学活性ニペコチン酸誘導体の製造方法 |
WO2022228318A1 (zh) * | 2021-04-25 | 2022-11-03 | 长春金赛药业有限责任公司 | 含吲哚啉螺环类衍生物、其制备方法及其在医药上的应用 |
WO2024083164A1 (zh) * | 2022-10-21 | 2024-04-25 | 长春金赛药业有限责任公司 | 吲哚啉螺环类化合物的溶剂化物及其晶型、制备方法和应用 |
WO2024083160A1 (zh) * | 2022-10-21 | 2024-04-25 | 长春金赛药业有限责任公司 | 吲哚啉螺环类化合物的晶型、无定形物及二者的制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8332704D0 (en) * | 1983-12-07 | 1984-01-11 | Pfizer Ltd | Growth promotants for animals |
US5206235A (en) * | 1991-03-20 | 1993-04-27 | Merck & Co., Inc. | Benzo-fused lactams that promote the release of growth hormone |
-
1993
- 1993-12-02 IL IL107836A patent/IL107836A/en active IP Right Grant
- 1993-12-03 CA CA002110672A patent/CA2110672A1/en not_active Abandoned
- 1993-12-08 EP EP93309868A patent/EP0662481B1/en not_active Expired - Lifetime
- 1993-12-08 AT AT93309868T patent/ATE178070T1/de not_active IP Right Cessation
- 1993-12-08 DZ DZ930130A patent/DZ1735A1/fr active
- 1993-12-08 DE DE69324148T patent/DE69324148T2/de not_active Expired - Fee Related
- 1993-12-08 ES ES93309868T patent/ES2129072T3/es not_active Expired - Lifetime
- 1993-12-10 HR HR931484A patent/HRP931484A2/hr not_active Application Discontinuation
- 1993-12-10 SI SI9300647A patent/SI9300647A/sl unknown
- 1993-12-10 JP JP5341449A patent/JP2509147B2/ja not_active Expired - Lifetime
- 1993-12-10 MX MX9307851A patent/MX9307851A/es not_active IP Right Cessation
- 1993-12-10 AU AU52321/93A patent/AU673017B2/en not_active Ceased
- 1993-12-10 PH PH47421A patent/PH31168A/en unknown
- 1993-12-11 CN CN93112857A patent/CN1040432C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN1092767A (zh) | 1994-09-28 |
CN1040432C (zh) | 1998-10-28 |
JPH0797367A (ja) | 1995-04-11 |
DE69324148D1 (de) | 1999-04-29 |
AU5232193A (en) | 1994-06-23 |
ES2129072T3 (es) | 1999-06-01 |
IL107836A0 (en) | 1994-04-12 |
HRP931484A2 (en) | 1996-04-30 |
PH31168A (en) | 1998-03-20 |
CA2110672A1 (en) | 1994-06-12 |
JP2509147B2 (ja) | 1996-06-19 |
AU673017B2 (en) | 1996-10-24 |
IL107836A (en) | 1998-01-04 |
ATE178070T1 (de) | 1999-04-15 |
EP0662481A1 (en) | 1995-07-12 |
DE69324148T2 (de) | 1999-10-28 |
SI9300647A (en) | 1994-09-30 |
DZ1735A1 (fr) | 2002-02-17 |
EP0662481B1 (en) | 1999-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2177538T3 (es) | Espiro piperidinas y homologos que promueven la liberacion de la hormona del crecimiento. | |
MY131439A (en) | Spiro piperidines and homologs promote release of growth hormone | |
MX9307851A (es) | Las espiropiperidinas y homologos promueven la liberacion de la hormona del crecimiento. | |
IL101206A0 (en) | Benzo-fused lactams,their preparation and pharmaceutical compositions containing them | |
ZA88152B (en) | Sustained release growth hormone compositions for parenteral administration and their use | |
ATE266658T1 (de) | Amido-spiropiperidine promovieren die freisetzung von wachstumshormonen | |
ITMI910705U1 (it) | Manufatti per l'alimentazione stimolatori dell'assunzione del cibo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |